metastatic castrate resistant prostate cancer (mCRPC)

2 total trials 1 recruiting

Filter these 2 trials by phase, country, sponsor and more.

Open in Search →

A clinical trial to learn about the effects of DZR123 and JSB462 given together in men with advanced prostate cancer that has stopped respon … Recruiting

2025-521880-10-00 9 2026-02-16
Investigation of Radium-223 dichloride (Xofigo), a treatment that gives off radiation that helps kill cancer cells, compared to a treatment … Recruitment ended

2023-505830-89-00 6 2020-08-05

Showing 1–2 of 2 trials